Close Icon

Clinical Insights

Medical monitoring is essential to ensuring patient safety and proving the efficacy of treatments under study during clinical trials. The integration of patient safety and subject-level data from your EDC, ePRO, labs, and other systems is driven by the Study Data Tabulation Model (SDTM) standards from the Clinical Data Interchange Standards Consortium (CDISC). Saama enhances your analytics capabilities for more accurate review and more informed decision-making. What’s more, Saama’s revolutionary Deep Learning Intelligent Assistant (DaLIA), lets you query your data for immediate answers to thousands of common questions, without having to wait for access to subject matter experts at your company.

Learn More

Use Cases/Value Drivers
Holistic Patient Data Review
Graphical patient profiles, which include multiple time-series charts in one location, provide a holistic view of every patient. Lab value averages—by cohort and visit—provide insights into subject trends.
Data Review Tracking
Dynamic line listings highlight new and changed data, to simplify the medical review process.
Data Reconciliation
When your entire medical review process is automated, you can easily highlight discrepancies, handle exceptions, and create and manage auditable tasks for items needing additional investigation.
Safety & Efficacy Signal Analysis
Issues related to adverse events and protocol deviations are easily identified and categorized for faster resolution.
Clinical Data Standardization
Data from disparate sources is aggregated into a Unified Study Data Model, which makes it easy to analyze events and create and distribute meaningful reports.

Saama can put you on the fast track to clinical trial process innovation.

Get Started

Terms & Conditions

By inquiring about Saama’s Database Lock in a Day, you agree to be contacted by Saama and to allow Saama to use, maintain, store, and protect your personal data in accordance with our Privacy Policy.

Eligibility details are for informational purposes only. Saama, in its sole discretion, will determine your eligibility based on the information you disclose as part of the intake process. If Saama determines that you are eligible to participate, you will be notified by separate email. Eligibility depends on certain criteria, such as the size of your company, the types of clinical trials you sponsor, and the number of patients in–and stages of–your current clinical trials.

By completing the request form, you represent that you have authority to proceed on behalf of your company. Should you agree to participate, you agree to reasonably cooperate with Saama in following the guidelines and procedures required for integrating, standardizing, and analyzing your data. Participation requires the use of our Smart Data Quality application, a technology-agnostic AI engine that sits on top of your current infrastructure. The application can be used immediately, and you’re only charged for the services you use based on a predetermined estimate.

Information you share with Saama during your participation may be anonymized and/or aggregated, and made available publicly in Saama marketing materials. This information may include: types of systems and processes involved, types of departments involved, and size and regional location of your company. Such information will never be directly associated with you, nor will you or your company be identifiable without express written permission.